Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

Germany flag Germany · Delayed Price · Currency is EUR
1.310
-0.010 (-0.76%)
Last updated: Dec 5, 2025, 8:05 AM CET
-17.61%
Market Cap 7.30B
Revenue (ttm) 33.60B
Net Income (ttm) 675.86M
Shares Out n/a
EPS (ttm) 0.18
PE Ratio 10.81
Forward PE 12.32
Dividend 0.03 (2.68%)
Ex-Dividend Date Jul 16, 2025
Volume n/a
Average Volume 10
Open 1.310
Previous Close 1.320
Day's Range 1.310 - 1.310
52-Week Range 1.160 - 1.630
Beta n/a
RSI 52.94
Earnings Date Mar 26, 2026

About FRA:S1R

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1994
Employees 49,402
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol S1R
Full Company Profile

Financial Performance

In 2024, FRA:S1R's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.